← Browse by Condition
Medical Condition

bladder cancer

Total Trials
19
Recruiting Now
19
Trial Phases
Phase 1, Phase 2, Phase 3
NCT07324798
Recruiting

Adaptive Radiotherapy for Genitourinary Cancers

Enrollment
60 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →
NCT06973161
Recruiting

ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors

Enrollment
105 pts
Location
United States, Austr...
Sponsor
AstraZeneca
View Trial →
NCT07339761
Recruiting

Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study

Enrollment
30 pts
Location
Denmark
Sponsor
University of Aarhus
View Trial →
NCT04923178
Recruiting

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Enrollment
1,100 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT05899361
Recruiting

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Enrollment
10 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT04564781
Recruiting

Predicting BCG Response

Enrollment
400 pts
Location
United States, Japan
Sponsor
Cedars-Sinai Medical Center
View Trial →
NCT04235764
Recruiting

En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device

Enrollment
25 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT07327489
Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

Enrollment
2,000 pts
Location
United States
Sponsor
Elephas
View Trial →
NCT04724018 Phase 1, Phase 2
Recruiting

Sacituzumab Govitecan Plus EV in Metastatic UC

Enrollment
106 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT03787056
Recruiting

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Enrollment
410 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT05783271
Recruiting

Validity of Parametric MRI Using VIRADS

Enrollment
58 pts
Location
Egypt
Sponsor
Assiut University
View Trial →
NCT05726786 Phase 3
Recruiting

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

Enrollment
232 pts
Location
Switzerland
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT07204132
Recruiting

Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy

Enrollment
180 pts
Location
China
Sponsor
Changhai Hospital
View Trial →
NCT05790850
Recruiting

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

Enrollment
30 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT05739968
Recruiting

Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients

Enrollment
120 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT03185468 Phase 1, Phase 2
Recruiting

Intervention of Bladder Cancer by CAR-T

Enrollment
20 pts
Location
China
Sponsor
Shenzhen Geno-Immune Medical I...
View Trial →
NCT05102110
Recruiting

Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.

Enrollment
450 pts
Location
United Kingdom
Sponsor
Origin Sciences
View Trial →
NCT04916990
Recruiting

Improving Care for Rural Patients With Solid Tumors

Enrollment
320 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06427824
Recruiting

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

Enrollment
85 pts
Location
United States
Sponsor
University of Chicago
View Trial →